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Summary. In this study, we examined the appearance of 
vascular endothelial growth factor (VEGF) in the 
femoral head of the growing rat using an 
immunocytochemical technique. Our results showed 
VEGF-immunopositive cells existed in the inner region 
and peripheral region of the femoral head at each 
developmental stage. In the 19-day-old fetus, 
immunopositive mesenchymal cells were demonstrated 
in the peripheral region of the femoral head. At 1 to 10 
days after birth, VEGF immunoreactivities were 
observed in the osteoblasts, osteoclasts, periosteum, 
perichondrium and cartilage matrix of the femur. At 15 
days after birth, VEGF immunoreactive chondrocytes 
appeared in the apex area of the femoral head. In this 
stage, the femoral head is still constituted by 
chondrocytes and no apparent vascular formation has 
been observed. Thereafter, the immunopositive 
chondrocytes in the femoral head increased in number. 
The penetration of capillaries was recognized within the 
ligament of the femoral head at 60 days after birth. The 
results indicate that some chondrocytes in the femoral 
head produce VEGF before the beginning of 
ossification, and that VEGF may play an important role 
in the penetration of blood vessels into the femoral head 
from the ligament of the femoral head. 
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lntroduction 
Vascular endothelial growth factor (VEGF) is known 
to stimulate endothelial cell growth and angiogenesis 
(Ferrara and Henzel, 1989; Gospodarowicz et al., 1989; 
Leung et al., 1989), and to act as a vascular permeability 
factor (VPF) to induce rnicrovascular hyperpermeability 
(Senger et al., 1983; Connolly et al., 1989). Furthermore, 
Horner et al. (1999) reported the immunolocalization of 
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VEGF in human neonatal growth plate cartilage. They 
demonstrated that hypertrophic chondrocytes produced 
VEGF and suggested that VEGF may play a key role in 
the regulation of vascular invasion of the growth plate. 
Recently, Gerber et al. (1999) reported the role of VEGF 
in endochondral bone formation of the mouse. They 
indicated that VEGF is an essential coordinator of 
chondrocyte death, chondroclast function, extracellular 
matrix remodeling, angiogenesis and bone formation in 
the growth plate. Furthermore, chondrocytes originate 
from pluripotent mesenchymal progenitors which also 
give rise to osteoblasts, adipocytes and other cell types 
(Rodan and Noda, 1991). The expression of VEGF is 
upregulated with increasing differentiation of 
osteoblasts, adipocytes and myoblasts, suggesting that 
the production of VEGF is a common event linked to the 
differentiation of mesenchyme-derived cells (Claffey et 
al., 1992; Harada et al., 1994). 
It is also well known that VEGF is produced in 
various normal tissues (Fan and Iseki, 1998), embryos 
and tumors (Ferrara and Davis-Smith, 1997). However, 
little information is available about the occurrence of 
VEGF during bone formation in the femoral head of the 
growing rat. 
In this study, therefore, we investigated the 
appearance of VEGF in the femoral head of the growing 
rat using an immunocytochemical technique to clarify 
the role of VEGF in the bone formation and 
angiogenesis. 
Materials and methods 
This study was carried out after permission had been 
granted by the Committee on Animal Experimentation, 
Kurume University. Wistar strain rats (19-day fetus and 
1-60 day-rats) were used in this study. 
At least five animals at each stage were sacrificed by 
decapitation under deep anaesthesia at 10 o'clock am. 
The femurs of each stage were fixed in Bouin solution 
for 24 hr - 2 weeks. Tissue samples were dehydrated 
through a series of solutions with increasing 
concentrations of ethanol. Tissues were embedded in 
paraffin, and serial sagittal sections at 4 p m  were 
mounted on glass slides. The preparations of the femur 
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were stained with Haematoxylin-Eosin and toluidine 
blue to permit observation of the general structure of the 
femur at each developmental stage. 
lmmunocytochemistry 
Primary antibodies generated against human 
recombinant VEGF165 were used a s  immuno- 
cytochemical probes (obtained from NeoMarkers, USA, 
diluted 1:500). This polyclonal antibody recognizes 
multiple isofoms of VEGF containing 206-, 188-, 165- 
and 121-amino acid residues in human, mouse and rat. 
Immunocytochemical staining was performed with a 
Histofine kit (Nichirei, Japan). In brief, sections were 
deparaffinized in xylene, hydrated in a graded ethanol 
series, and washed in phosphate-buffered saline (10 mM 
sodium phosphate, 0.15M sodium chloride, pH 7.5; 
PBS). Al1 procedures were performed at room 
temperature, and incubations were performed in closed 
humid chambers. First,  the tissue sect ions were 
incubated for 3 0  min in methanol containing 0.3% 
hydrogen peroxide to block endogenous peroxidase 
activities, and were then washed in PBS. To reduce 
nonspecific staining caused by the biotinylated anti- 
rabbit IgG, sections were treated with normal goat serum 
for 30 min, and then washed in PBS. Primary antisera 
were applied to the sections for 2 to 24 h, and the 
biotinylated anti-rabbit IgG and peroxidase-conjugated 
streptavidin were applied for 1 h each. The final reactive 
products were visualized with 3,3'-diaminobenzidine 
tetrahydrochloride in 50 mM Tris-HC1 buffer @H 7.6) 
-containing 0.003% hydrogen peroxide (Hsu et al., 1981). 
The sect ions were then counter-stained with 
haematoxylin, washed in running water, dehydrated 
through an increased ethanol series, and mounted in 
Diatex (Ab Wilh Becker, Sweden). To confirm the 
specificity of the immunocytochemical staining, the 
primary antiserum was replaced by PBS. 
Results 
In the 19-day-old fetus, VEGF-immunopositive cells 
were observed in the immature chondrocytes at the 
peripheral region of the femoral head. Moreover, 
mesenchymal cel ls  around the femoral head 
immunoreacted with the VEGF165 antibody (Fig. 1). To 
confirm the specificity of this immunoreaction, the 
primary antiserum was replaced by PBS, as the results 
the immunopositive reactions were not demonstrated. 
At one day after birth, immunoreactivities against 
this VEGF antibody were demonstrated in the 
periosteum and perichondrium of the femur. Moreover, 
osteoblasts and osteoclasts in the proximal end of 
diaphysis also immunoreacted with this VEGF-antibody 
(Figs. 2a,b). Immature chondrocytes, which were 
observed in the 19-day-old fetus, were not found in the 
femoral head. In this stage, the chondrocytes in this 
region exhibited no immunoreaction with the VEGF 
antibod y. 
At four days after birth, weak but apparent VEGF 
immunoreactivities appeared in the chondrocytes in the 
proliferating and hypertrophic zones and in the cartilage 
matrix of the femoral head (Fig. 2c,d). The  
immunopositive periosteum, perichondrium, osteoblasts 
and osteoclasts were obsewed like as one day after birth. 
Some microvessels were observed in the metaphysis and 
periosteum. 
At seven days after birth, more intense immuno- 
Rg. 1. Femoral head of the 1 Q-day-old 
fetus. VEGF immunopositive immature 
chondrocytes at the peripheral region of 
the femoral head (arrow heads) and 
mesenchymal cells around the femoral 
head are shown. x 90 
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positive reactions were observed in chondrocytes, 
osteoblasts and osteoclasts. Especially, chondrocytes in 
the proliferating and hypertrophic zones exhibited more 
intense immunoreactions. Cartilage matrix around the 
immunopositive chondrocytes also demonstrated VEGF 
immunoreactivities (Figs. 3a-c). 
At 1 0  days after birth, more intense immuno- 
reactivities were detected in the cartilage matrix at the 
peripheral region of the femoral head (Fig. 3d). Intense 
immunoreactivities appeared at this time in the 
chondrocytes and cartilage matrix around these 
chondrocytes at the apex area of the femoral head (Fig. 
3e). 
At 1.5 days after birth, immunoreactive VEGF cells 
appeared in the apex area of the femoral head. Moreover, 
the perichondrial cells at the apex of the femoral head 
exhibited VEGF immunoreaction (Fig. 4a). In this stage, 
the femoral head still consisted of chondrocytes, and no 
apparent vascular formation was observed in the femoral 
head. 
At 20  days after birth, VEGF-immunopositive 
chondrocytes in the apex area of the femoral head 
increased in number. Moreover, these immunopositive 
chondrocytes developed and further increased in number 
at 30 days after birth (Fig. 4b). 
At 6 0  days after birth, a few capillaries were 
observed in the ligament of the femoral head. These 
capillaries penetrated into the apex area of the femoral 
head where VEGF-immunopositive chondrocytes had 
previously been identified (Fig. 4c). 
Discusslon 
This is the first report demonstrating the appearance 
of VEGF in the femoral head in the growing rat. It has 
been reported that VEGF stimulates the differentiation of 
mesenchyme-derived cells (Claffey et al., 1992; Harada 
et al., 1994). In this study, many VEGF-immunopositive 
mesenchymal cells were found around the femoral head 
in the 19-day-old fetus. These mesenchymal cells 
demonstrated no immunoreaction with the PBS which 
replaced by primary antiserum. Therefore, we consider 
that these VEGF immunoreactions are specific.  
Moreover, the results indicate that VEGF produced by 
Fig. 2. a and b. Boondaty afea of the femoral head and metaphysis i m m u m  wifh VlE3F mübody. 1- ~~, , 
periosteurn and perichondrium are preaent in íhe one-day-dd rat a, x 70; b, x 200. c Prtd d. ImmM d i a g e  nratifx {arrow kad@ and 
chondrocytes (arrows) appeared in the 4-day-old mi. c, x 80; d, x170 
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mesenchymal cells around the femoral head might 
induce angiogeneis toward the femur during early bone 
formation. 
After birth, VEGF was demonstrated in the early 
stage in the osteoblasts, osteoclasts, periosteum and 
perichondrium around the femoral head. VEGF, the 
endothelial cell-specific mitogen, is  an essential 
mediator of angiogenesis (Ferrara and Davis-Smith, 
1997), and angiogenesis is essential for bone growth and 
healing (Streeten and Brandi, 1990; Mori et al., 1998; 
Ryan et al., 1999), and the recruitment of osteoblasts 
coincides with vascular invasion (Holder, 1978; 
Carrington and Reddi, 1991). Therefore, VEGF 
produced in osteoblasts and osteoclasts might play a key 
role in the formation of microvessels at the metaphysis. 
Moreover, the existence of VEGF in the periosteum and 
Flg. 3. Saggital sections of the femur immunostained with VEGF 
antibody. a. Boundary area of the femoral head and metaphysis in the 
7-day-dd rat is shown. a, x 70. b and c. Higher magniíicatlon of the 
immunopositive chondrocytes and cartilage matrix. (b, x 140) and 
oktqblasts and osteoclasts (c, x 140) in the 7-day-old rat. d and e. 
BounfWy area of the femoral head and metaphysis (d, x 70), and the 
apex area uf the femoral head (e, x 140) in the 10-day-oid rat. VEGF 
immunoreactlvities were demonstrated in the chondrocytes and 
caftilagr matrix of both areas in the 10-day-old rat. 
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Flg. 4. a. Apex area of the femoral head immunostained with VEOF 
antibody in the 15-day-old rat. ImmunoposRive perichondrial cells and 
chondrocytes are shown. b. Apex area of the femoral head 
immunostained with VEGF antibody in the 30-day-old rat. 
lmmunopositiive chondrocytes developd and increased in number. c. 
Apex area of the femoral head stained with H&E in the 60-day-old rat. A 
few capilldes are present (arrow heads). a, x 50; b. x 250; c, x 60 
the perichondrium suggests that VEGF has an intimate 
relation with the angiogenesis in the periosteum and 
perichondrium. At a more advanced stage, VEGF 
appeared in the cartilage matrix in the peripheral region 
of the femoral head and in the chondrocytes at the 
proliferative and hypertrophic zones. It seems that 
VEGF demonstrated in the proliferative and 
hypertrophic zones may play a role in the regulation of 
vascular formation in the elongating femur. On the other 
hand, VEGF in the cartilage matrix might be secreted by 
chondrocytes, but VEGF immunoreactivity was not 
always demonstrated in chondrocytes in the peripheral 
region. It is considered that the physiological situation of 
the chondrocyte at this region is different from the 
proliferative and hypertrophic zones, further 
investigation is needed in this problem. 
In the young rat, VEGF was demonstrated in the 
chondrocytes at the apex area of the femoral head. The 
apex area of the femoral head is the presumptive 
secondary ossification area. On the surface of this 
region, a few capillaries penetrated within h e  ligament 
of the femoral head at 60 days after birth. Recently, 
Morini et al. (1999) reported that capiilary invasion into 
the femoral head fmt occurred in 9-week-old rats. These 
results indicate that VEGF appearing in the 
chondrocytes at the apex area of the femoral head may 
play an important role in the microvascular invasion 
from the ligament of the femoral head. In fact, the blood 
vessels from the ligament of the femoral head is 
not abundant, the femoral head is mainly supported 
by blood vessels coming from the metaphysis. We 
consider that the vessels coming from the metaphysis 
are induced by the VEGF secreted from the 
chondrocytes in the proliferative and hypertrophic 
zones. 
In conclusion, the early expression of VEGF at 
various sites during femoral head development indicates 
that VEGF plays a role in the regulation of angiogenesis 
at each site of endochondral bone formation. 
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